A Propensity Score Matched Comparison of Brand and Biosimilar Basal Insulin in Non-Critical Hospitalized Patients with Type 2 Diabetes Mellitus.

Adv Ther · 2019 · PMC6824369 · PMID 30900200

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

Patients treated with Lantus showed a trend towards lower mean post-breakfast and pre-lunch BG levels compared with those receiving Basalin, although these differences did not reach statistical significance (Table 2 , Fig. 2 c).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.